Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesReversible cerebral vasoconstriction syndrome
Practical Neurology, 09/21/09
Ducros A et al. – Reversible cerebral vasoconstriction syndrome is characterised by severe headaches with or without seizures and focal neurological deficits, and constriction of cerebral arteries which resolves spontaneously in 1–3 months.
- The reversible cerebral vasoconstriction syndrome is more frequent than previously thought and affects patients of both genders, with a female preponderance.
- It is attributed to a transient disturbance in the control of cerebral vascular tone leading to multifocal arterial constrictions and dilatations.
- Some cases are spontaneous while others (60%) are secondary, mostly to exposure to vasoactive substances and to the postpartum state.
- The syndrome has a characteristic course; the onset is sudden followed by a monophasic course, generally without new events after 1 month. The main pattern is of recurrent thunderclap headaches.
- Cortical subarachnoid haemorrhage, intracerebral haemorrhage, seizures and the reversible posterior encephalopathy syndrome are early complications, occurring mainly within the first week.
- Ischaemic events, including transient ischaemic attacks and cerebral infarction, occur later than any haemorrhagic strokes, mainly during the second week.
- Diagnosis requires the demonstration of the characteristic "string of beads" on cerebral angiography, the definitive diagnosis being made when a later angiogram shows resolution or at least marked improvement of the arterial abnormalities after about 12 weeks.
- Nimodipine is the proposed treatment but in the authors' experience does not seem very effective; randomised trials are needed.
- Relapses do occur but are rare
Related Articles
Single stage, transmastoid approach for otogenic intracranial abscess
The Journal of Laryngology & Otology, 11/05/09
Relevance Score: 45%
Diagnosis and Treatment of Intracranial Immature Teratoma
Pediatric Neurosurgery, 11/13/09
Relevance Score: 43%
Cerebral Vasospasm Following Traumatic Subarachnoid Hemorrhage
Journal of Research in Medical Sciences, 11/02/09
Relevance Score: 43%
Intracranial artery calcification in hemodialysis patients
International Urology and Nephrology, 10/26/09
Relevance Score: 43%
Tumefactive intracranial presentation of precursor B-cell acute lymphoblastic leukemia
Pediatric Radiology, 10/12/09
Relevance Score: 43%
Today in Headache...keeping you current
Receive free subspecialty "5-minute updates" via email
Epidemiology of headache in Arab countries
The Journal of Headache and Pain, 12/04/09
Economic Evaluation of Pharmacotherapy of Migraine Pain: A Review of the Literature
Journal Of Pain & Palliative Care Pharmacotherapy, 12/02/09
The validity of questionnaire-based diagnoses: the third Nord-Trondelag Health Study 2006-2008
The Journal of Headache and Pain, 12/01/09
Sponsor
Article Search
Sponsor